Colorectal Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Colorectal Cancer stocks.

Colorectal Cancer Stocks Recent News

Date Stock Title
May 22 SNY Sanofi says asthma candidate rilzabrutinib buoyed by phase 2 results
May 22 SNY Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M
May 22 SNY Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
May 22 CCCC We Think C4 Therapeutics (NASDAQ:CCCC) Can Afford To Drive Business Growth
May 22 SNY First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
May 22 SNY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
May 22 REGN Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
May 22 SNY Better Buy: Inovio Pharmaceuticals vs. Novavax
May 22 REGN Regeneron faces new biosimilar threats; an AI biotech lays off staff
May 22 SNY 3 Things You Need to Know If You Buy Novavax Today
May 22 SNY Sanofi enters partnership to enhance drug development using AI
May 22 SNY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
May 22 CRDF Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data
May 21 ERAS Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
May 21 SNY Sanofi (SNY) Signs Deal for AI-Powered Drug Development
May 21 SNY ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
May 21 SNY Sanofi teams up with Formation Bio, OpenAI on AI-driven drug development
May 21 SNY Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
May 20 SNY Sanofi: Information concerning the total number of voting rights and shares - April 2024
May 20 REGN Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Some risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.Bowel cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. This is then followed by medical imaging to determine if the disease has spread. Screening is effective for preventing and decreasing deaths from colorectal cancer. Screening, by one of a number of methods, is recommended starting from the age of 50 to 75. During colonoscopy, small polyps may be removed if found. If a large polyp or tumor is found, a biopsy may be performed to check if it is cancerous. Aspirin and other non-steroidal anti-inflammatory drugs decrease the risk. Their general use is not recommended for this purpose, however, due to side effects.Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely are usually not curable, with management being directed towards improving quality of life and symptoms. The five-year survival rate in the United States is around 65%. The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery and the person's overall health. Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases. In 2012, there were 1.4 million new cases and 694,000 deaths from the disease. It is more common in developed countries, where more than 65% of cases are found. It is less common in women than men.

Browse All Tags